Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer

In colorectal cancer, immune effectors may be determinative for disease outcome. Following curatively intended combined-modality therapy in locally advanced rectal cancer metastatic disease still remains a dominant cause of failure. Here, we investigated whether circulating immune factors might corr...

Descripción completa

Detalles Bibliográficos
Autores principales: Meltzer, Sebastian, Kalanxhi, Erta, Hektoen, Helga Helseth, Dueland, Svein, Flatmark, Kjersti, Redalen, Kathrine Røe, Ree, Anne Hansen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085198/
https://www.ncbi.nlm.nih.gov/pubmed/27145458
http://dx.doi.org/10.18632/oncotarget.8995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085198/
https://www.ncbi.nlm.nih.gov/pubmed/27145458
http://dx.doi.org/10.18632/oncotarget.8995

Ejemplares similares